A global biopharma with a U.S. headquarters in Montgomery County is gearing up to go public on a U.S. exchange.

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...

Titan America SA (TTAM) has filed to raise $100 million in an IPO of its common shares, according to an SEC F-1 registration ...

Laxmi Dental IPO received stellar demand from investors as the issue was subscribed by 114.42 times in total. As the bidding ...

Kuwait – Kuwait Financial Centre “Markaz” released its research report titled “Initial Public Offerings (IPO) in the GCC markets”, stating that the region has seen 53 offerings during the year 2024 ...

PARIS - Beauty M&A may be slow Stateside, but global IPO season is about to kick off - again. Initial public offerings were ...

Zepto’s valuation in the listing remains to be seen. It was most recently valued at $5 billion. The Trump administration was ...

The participants discussed the cases in which the bank is liable to compensate for the decrease in the value of the shares, in addition to defining the concept of offering shares for trading on the ...

This National Startup Day, government and policy action must realign with the needs of the startup ecosystem for 2025 ...

The IPO of Quadrant Future Tek ... Quadrant Future Tek is a research-oriented company engaged in developing new-generation train control and signalling systems that offer the highest level ...